A large prospective cohort study demonstrated that elevated sVAP-1 levels are strongly associated with an increased risk of major adverse cardiovascular events (MACE), including CHD, unstable angina, acute myocardial infarction, coronary revascularization, and stroke (109). The gene discussed is SNAP47; the disease is coronary artery disorder.